摘要
背景:丝素蛋白(SF)是一种从家蚕(Bombyx mori)获得的天然原料,已被广泛用作具有优异机械性能的生物材料。据报道,SF是各种药物输送系统以及药物输送载体的有利生物聚合物之一。 目的:本综述总结了丝素蛋白在各种给药系统中的综合应用,并通过对丝素蛋白作为聚合物进行确定性评估,提出了目前的机会和要求。 结果:SF已被报道为用于各种给药系统以及给药载体的有益生物聚合物之一。 SF是无法估量的,因为它具有无毒和无抗原特性,除了在较低温度下储存时形成坚固性。与其他聚合物生物材料不同,SF在水性体系中以规定的温度,压力和pH值再生,这是其在配方中的主要优势之一。 SF纳米颗粒也用于递送蛋白质和肽。最近,SF已被用于递送抗癌剂如紫杉醇,多柔比星,氟尿苷和甲氨蝶呤,并且包括天然产物姜黄素,与其常规形式相比已显示出引起显着的生物活性。有趣的是,SF已被证明是一种用于植入物和注射药物递送应用的有前途的生物材料。 结论:在本综述中,我们总结了SF的物理和化学性质,生物相容性和非免疫原性特征及其在各种给药系统中的应用。
关键词: 生物材料,丝素蛋白,纳米粒,抗癌,药物传递,生物聚合物。
图形摘要
Current Drug Targets
Title:Silk Fibroin Based Drug Delivery Applications: Promises and Challenges
Volume: 19 Issue: 10
关键词: 生物材料,丝素蛋白,纳米粒,抗癌,药物传递,生物聚合物。
摘要: Background: Silk Fibroin (SF), a natural source material obtained from Bombyx mori, has been widely enlisted as biomaterial having outstanding mechanical properties. SF has been reported as one of the propitious bio-polymers for various drug delivery systems, as well as drug delivery vehicle.
Objective: This review is a summary of comprehensive applications of silk fibroin in various drug delivery systems, and also to present the current opportunities and requirements by furnishing a definitive assessment on silk fibroin as a polymer.
Results: SF has been reported as one of the propitious bio-polymers for various drug delivery systems, as well as drug delivery vehicle. SF is inestimable owing to its non-toxic and non-antigenic character, except for the firmness formation whilst being stored at lower temperature. Unlike other polymeric biomaterials, SF is regenerated in aqueous systems in defined temperature, pressure and pH, which is one of its major advantages in formulation. SF nanoparticles are also used to deliver proteins and peptides. Recently, SF has been used to deliver anti-cancer agents like paclitaxel, doxorubicin, floxuridine, and methotrexate, and including the natural product curcumin, has shown to elicit significant biological activity when compared to their conventional form. Interestingly, SF has shown to be a promising biomaterial for implantables and injectable drug delivery applications.
Conclusion: In the present review, we have summarized the physical and chemical properties, biocompatibility and non-immunogenic characters of SF and its applications in various drug delivery systems.
Export Options
About this article
Cite this article as:
Silk Fibroin Based Drug Delivery Applications: Promises and Challenges, Current Drug Targets 2018; 19 (10) . https://dx.doi.org/10.2174/1389450119666171227205525
DOI https://dx.doi.org/10.2174/1389450119666171227205525 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Psychopharmacology of Appetite: Targets for Potential Anti-Obesity Agents
Current Medicinal Chemistry - Central Nervous System Agents Nonalcoholic Fatty Liver Disease (NAFLD) for Primary Care Providers: Beyond the Liver
Current Hypertension Reviews Bariatric Surgery: Indications, Safety and Efficacy
Current Pharmaceutical Design Developments in Targeted Therapy of Advanced Gastrointestinal Stromal Tumors
Recent Patents on Anti-Cancer Drug Discovery Immunosensors in Early Cancer Diagnostics: From Individual to Multiple Biomarker Assays
Current Medicinal Chemistry Advances in the Researches on the Biological Activities and Inhibitors of Phosphatidylinositol 3-kinase
Anti-Cancer Agents in Medicinal Chemistry Transactivation of ErbB Receptors by Leptin in the Cardiovascular System: Mechanisms, Consequences and Target for Therapy
Current Pharmaceutical Design α7 Nicotinic Acetylcholine Receptor Subunit in Angiogenesis and Epithelial to Mesenchymal Transition
Current Drug Targets Roles of Epithelial-Mesenchymal Transition in Cancer Drug Resistance
Current Cancer Drug Targets New Issues about Nitric Oxide and its Effects on the Gastrointestinal Tract
Current Pharmaceutical Design Regulatory T Cells and Allergic Disease
Inflammation & Allergy - Drug Targets (Discontinued) Clinical Proteomics in Cancer Research – Promises and Limitations of Current Two-Dimensional Gel Electrophoresis
Current Medicinal Chemistry The Role of Metabolism in Toxicity of Polycyclic Aromatic Hydrocarbons and their Non-genotoxic Modes of Action
Current Drug Metabolism Anticancer Potential of Dietary Natural Products: A Comprehensive Review
Anti-Cancer Agents in Medicinal Chemistry Perspectives of Engineered Marine Derived Polymers for Biomedical Nanoparticles
Current Pharmaceutical Design Cyclin-Dependent Kinase Inhibitors: Cancer Killers to Neuronal Guardians
Current Medicinal Chemistry Nutritional Support in Cancer
Current Nutrition & Food Science The ERK 1 and 2 Pathway in the Nervous System: From Basic Aspects to Possible Clinical Applications in Pain and Visceral Dysfunction
Current Neuropharmacology The Proteolytic Activation of Angiogenic and Lymphangiogenic Growth Factors in Cancer – Its Potential Relevance for Therapeutics and Diagnostics
Current Medicinal Chemistry The Risk of Adverse Drug Reactions in Older Patients: Beyond Drug Metabolism
Current Drug Metabolism